Viewing nowGlimed Tablet 2 mg (Glimepiride)
Glimepiride 2mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.

MFDS item code 200401285 · Notified 2004.04.07 · Insurance code 641700040
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used to improve blood sugar control in patients with type 2 diabetes. It effectively manages blood sugar while assisting dietary and exercise regimens. It can also be administered as monotherapy and can be used in combination with other oral hypoglycemic agents or insulin if blood sugar control is insufficient. Especially in cases where blood sugar control is difficult with sulfonylureas or metformin monotherapy, combining this medication with metformin enhances therapeutic effects. This medication aids in the management of blood sugar and improves diabetes treatment.
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. Take this medication orally once daily. Take this medication before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medication. 1. Monotherapy 1) Initial dose and dose determination For patients who have not previously received medication, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional effect, although some patients have achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg per day is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medication. 2) Subsequent dose adjustment As diabetes control may improve during treatment, the need for this medication may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medication There is no exact dose equivalence between this medication and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medication, it is advisable to follow the method described under Initial Dose. That is, start with 1 mg per day and adjust the dose at 1 ~ 2-week intervals. The potency and duration of action of the previous medication should be taken into consideration. 4) Dose adjustment during treatment Blood glucose and/or urine glucose levels should be measured regularly while taking this medication, and regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia is promptly controlled by taking sugar immediately. Hypoglycemia may recur after treatment with a sulfonylurea, even if it was initially managed successfully. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medication and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medication once daily with the first meal, and start insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin doses should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medication, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medication is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medication. However, efforts should be made to determine the minimum effective dose of each medication for blood glucose control. There is a risk of hypoglycemia when this medication is used concomitantly with metformin, and the risk may increase. Appropriate precautions should be taken.
This medication should not be administered to patients with insulin-dependent diabetes or those with diabetic ketoacidosis or diabetic coma. Patients with hypersensitivity to this medication or with an allergy to sulfonylureas should not use it. Patients with severe liver or kidney dysfunction are recommended to avoid this medication and switch to insulin therapy. Women who are pregnant or may become pregnant, and those who are breastfeeding should not use this medication. Patients with severe infections, before and after surgery, or with severe trauma are advised to implement insulin therapy for safety. If gastrointestinal disorders such as diarrhea or vomiting occur, absorption of food may be hindered, increasing the risk of hypoglycemia, so caution is needed. This medication contains lactose, so patients with genetic issues such as lactose intolerance or galactose intolerance should not use it. During the initial dosing, the risk of hypoglycemia is high, so blood sugar should be checked frequently and symptoms should be carefully monitored, particularly in the elderly, malnourished patients, those who skip meals, and alcohol consumers. Patients with weak kidney or liver function may be more sensitive to this medication, so dose adjustments may be necessary. Patients with other endocrine disorders or those taking other medications may experience hypoglycemic symptoms, so consultation with a physician is essential. Caution should also be exercised in patients with allergies to additives in this medication. Hypoglycemic symptoms may include headache, severe hunger, nausea, fatigue, confusion, loss of consciousness, etc., so immediate intake of sugar or informing medical personnel is necessary when these symptoms arise. Blurred vision or gastrointestinal disturbances, liver dysfunction, blood abnormalities, and allergic reactions may occur rarely, so report any unusual symptoms to a doctor immediately. This medication should be taken regularly, and dietary and exercise regimens need to be followed; quickly ingesting sugar during hypoglycemic events is important. In stressful situations or during surgery or infections, blood sugar control may become difficult, thus transitioning to insulin therapy may be required. Drug interactions may occur, so inform medical personnel of any other medications being taken. Women who are pregnant or breastfeeding should not use this medication and should choose alternative treatments. It is not used in children under 18 years of age as safety and efficacy have not been established. Elderly patients may require dose adjustments due to decreased kidney function. In case of overdose, severe hypoglycemia may occur, necessitating immediate appropriate treatment at a medical facility.
Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorders, anxiety, aggression, decreased concentration, decreased agility or energy, depression, confusion, speech abnormalities, aphasia, visual impairment, tremors, incomplete paralysis, sensory abnormalities, dizziness, weakness, loss of self-control, temporary mental confusion, brain convulsions, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cool and moist skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, elevated liver enzymes, liver dysfunction, bile secretion disorders, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, neutropenia, agranulocytosis, pancytopenia, itching, hives, rash, dyspnea, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photodermatosis, decreased serum sodium concentration, taste disorder, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, arthralgia, dyspepsia, facial edema, erectile dysfunction, facial flushing, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air or moisture from entering. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius. This ensures the medication retains its effectiveness for a longer period.
Green snowman-shaped tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 2mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.